PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma

INTRODUCTION: Prenylated Rab acceptor 1 domain family member 2 (PRAF2), a novel oncogene, has been shown to be essential for the development of several human cancers; however, its role in hepatocellular carcinoma (HCC) remains unclear. MATERIALS AND METHODS: PRAF2 mRNA and protein expressions were e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun-Hua, Liu, Li-Li, Liao, Ding-Zhun, Zhang, Mei-Fang, Fu, Jia, Lu, Shi-Xun, Chen, Shi-Lu, Wang, Hong, Cai, Shao-Hang, Zhang, Chris Zhiyi, Zhang, Hui-Zhong, Yun, Jing-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065608/
https://www.ncbi.nlm.nih.gov/pubmed/30100755
http://dx.doi.org/10.2147/CMAR.S166789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065608/
https://www.ncbi.nlm.nih.gov/pubmed/30100755
http://dx.doi.org/10.2147/CMAR.S166789

Ejemplares similares